Investors
2024 Second quarter announcement
We announced our second quarter 2024 results on Wednesday 31 July. Access our second quarter results and latest Annual Report below.
We’re confident in our future
With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Behind the science
Read our latest articles
‘Teenagers may feel invincible – but we’re at risk’: What you need to know about meningitis as post-COVID cases continue to rebound
‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it
‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’
‘My cough interferes with everything’: New research could help refractory chronic cough patients after decades of depression, pain, and sleep loss
Remission could be possible for people with asthma, giving them a new outlook on life
6 in 10 of adults over 50 have never heard of RSV, despite some being among those most at risk of infection
‘This could be a golden moment’: Is prevention the ‘medicine’ we need to end the HIV epidemic?
'Scientists need rich and accessible data at scale to make the best possible impact for patients’
‘We’ve seen an explosion in computing power’: Using AI, machine learning and data to unlock the mysteries of disease
Advanced technology is increasing the chances of improving outcomes for cancer patients
